Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Home Caregivers Administer Cannabis Legally for Dementia? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

As discussions about medical cannabis grow, many families caring for loved ones with dementia wonder whether a home caregiver can legally administer cannabis. While cannabis-based medicinal products (CBPMs) are legal in the UK, their use is heavily regulated, and dementia is not an approved condition. Home caregivers can only give cannabis under strict medical and legal supervision. 

Can medical cannabis be accessed legally for women’s health?

Legal Framework for Cannabis Use 

Cannabis-based products are classified as Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001. This means they can only be prescribed by a specialist doctor registered with the General Medical Council (GMC) and included on the Specialist Register (NHS England, 2023). 

Dementia is not one of the approved conditions for cannabis prescriptions under NICE guidance (NG144). Any cannabis prescribed for dementia symptoms is considered off-label and must be clinically justified and documented by a qualified specialist. 

Rules For Home Administration 

If a specialist prescribes a cannabis-based medicine for an off-label purpose, such as agitation or poor sleep, it must be dispensed through a licensed pharmacy and administered exactly as prescribed. 

Home caregivers may only administer cannabis if: 

  • The medicine is legally prescribed to the person in their care. 
  • They have clear written instructions from the prescriber or pharmacy. 
  • All doses are recorded on a Medication Administration Record (MAR). 
  • The product is securely stored in a locked cabinet. 

Any caregiver giving cannabis without a prescription or outside written instructions risks breaching controlled drugs legislation and could face criminal penalties. 

Ethical And Safety Considerations 

The Mental Capacity Act 2005 (UK legislation) requires that any decision to use or continue cannabis must be made with the person’s consent. If the person lacks capacity, a best-interest decision must be agreed by healthcare professionals and family members. 

The CQC Controlled Drugs Annual Report 2024 stresses that caregivers must maintain clear documentation, notify prescribers of side effects, and never alter doses independently. The Alzheimer’s Society also warns that unregulated cannabis or CBD products may be unsafe or interact with prescribed medicines. 

Clinical Bottom Line 

  • Home caregivers may only administer cannabis with a legal prescription and written authorisation. 
  • Dementia is not an approved indication under NICE or NHS guidelines. 
  • All administration must follow controlled-drug storage and record protocols. 
  • Unsupervised or unprescribed use is illegal. 

Educational Context: AlleviMed 

AlleviMed provides educational information on how UK regulations govern cannabis prescribing and administration. It helps families understand their responsibilities under controlled-drug law when supporting dementia care at home. 

Takeaway 

Home caregivers can only administer cannabis for dementia if prescribed by a registered specialist and documented under controlled-drug procedures. Without formal authorisation, administration is illegal. The safest approach is always to follow professional guidance and ensure all decisions align with medical, legal, and ethical standards. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories